title: Leading ordinary lives: a qualitative study of younger women's perceived functions of antidepressants.
abstract: BACKGROUND
  While the overall consumption of psychotropic medicines such as tranquillisers and hypnotics has declined, the consumption of the newer antidepressants--selective serotonin reuptake inhibitors (SSRIs) has increased drastically since their introduction. In order to understand the mechanisms underlying the use, it is important to gain insight into the users' perceptions about their medicine and use.
  
  
  OBJECTIVE
  To analyse younger women's perceived functions of SSRIs in their everyday lives.
  
  
  METHODS
  12 in-depth interviews and 6 re-interviews were conducted with a community-based sample of 21- to 34-year-old women taking SSRIs. The women were recruited through Danish pharmacies.
  
  
  RESULTS
  Prior to taking SSRIs the women struggled with their emotional problems, often in great frustration and distress. While taking SSRIs the women experienced that the medicine functioned both at a psychological and a social level. They believed that the medicine gave them resources to behave actively in a way that was not previously possible. They felt that the medicine use enabled them to concentrate on daily life activities other than dealing solely with their emotional problems. The women found that the medicine gave them back a sense of 'normality'.
  
  
  CONCLUSIONS
  The main finding in this paper is that the perceived functions of SSRIs were related to social meanings and goals in everyday life.
authors.affiliation: Department of Social Pharmacy, FKL-Research Centre for Quality in Medicine Use, Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen, Denmark. pini@dfh.dk
authors.forename: Pia
authors.initials: P
authors.lastname: Knudsen
authors.forename: Ebba Holme
authors.initials: EH
authors.lastname: Hansen
authors.forename: Kristin
authors.initials: K
authors.lastname: Eskildsen
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D003718:Denmark; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D010594:Pharmacies; D036301:Qualitative Research; D011788:Quality of Life / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012944:Social Support
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors